RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Palo Alto, CA · Sacramento, CA · +49 more sites
2 recruiting lupus studies with a site in Palo Alto, CA.
Sponsor: National Cancer Institute (NCI)
Palo Alto, CA · Sacramento, CA · +49 more sites
Sponsor: Alice Bertaina
Palo Alto, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.